Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox + Acyclovir Interaction
Moderateinteraction on record
Description
Acyclovir is eliminated by active tubular secretion; coadministration may increase concentrations of acyclovir and emtricitabine/tenofovir, increasing risk of adverse reactions.
Mechanism
Competition for active tubular secretion in kidneys
Source: NLP:elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate